Addressing the Unique Aspects of Rare Disease Product Commercialization

Experts Ryan Subhan and Emily Phillips highlight early planning, market education, and overcoming challenges in launching rare disease therapies. Watch now.

Part 2: Addressing the Unique Aspects of Rare Disease Product Commercialization

This video highlights the challenges of launching an expensive therapy for a rare disease, focusing on partnerships, planning, and tailored care. Watch now.

Part 1: Addressing the Unique Aspects of Rare Disease Product Commercialization

The video highlights the crucial role of advocacy groups and the importance of early, strategic planning for successfully launching rare disease treatments. Watch now.

Part 4: Navigating success during a rare disease product launch

The video outlines best planning, timing, and budgeting practices in rare disease product launches. Watch here.

Navigating success during a rare disease product launch

In this video, experts Kapil Raina, Chris Zealey, and Brian Williams, explore insights on successfully launching products in rare disease markets.

Part 3: Navigating success during a rare disease product launch

The video outlines key success factors in rare disease markets through the five P's: People, Product, Payers, Promotion, and Placement. Watch here.

Part 2: Navigating success during a rare disease product launch

Gain insights from Chief Commercial Officers on launching in the rare disease market. Watch here.

Market Access

Preparing for 2025: Financial and Operational Challenges of the Inflation Reduction Act

Essential Strategies for Manufacturers to Adapt Financially and Operationally Amidst Evolving Regulatory Landscapes and Market Pressures. Read the article to find out more.

Market Access

The Inflation Reduction Act: Updates and Considerations for Pharmaceutical Manufacturers

The Centers for Medicare & Medicaid Services (CMS) just announced the first set of drugs and biologics for price negotiations to be effective 2026. Read the article to find out more.

Part 1: Navigating success during a rare disease product launch

Explore the rare disease landscape, focusing on patients' diagnostic and treatment challenges, competitive dynamics, and tailored launch strategies.

Part 4: Finding an Experienced Strategic Partner for Commercial Drug Launch (Video)

In this video conversation with commercial experts from Herspiegel you'll learn how considering commercial viability early in the development process can significantly improve the launch success of new drugs by pharmaceutical and biotech companies.

Part 3: Leveraging a Proven Framework in the Drug Launch Process (Video)

Part 1: Value of Phase 2 Commercial Perspective for Drug Developments (VIDEO)

Part 2: Creating Credible Forecasts for Drug Development (Video)

Launching Life Science Brands: A Conversation with Experts on Commercial Readiness (VIDEO)

Market Access

New AMCP Dossier Format 5.0 Released

Learn key changes in the AMCP Dossier 5.0 format.

Market Access

Are you prepared for the Medicaid AMP cap removal starting January 1, 2024?

Currently, Medicaid rebates paid by drug manufacturers are capped at the quarterly Average Manufacturer’s Price (AMP) for each drug/biologic. The removal of the cap means ...

Launch Excellence

Navigating a Drug Launch: Part 4 – The Launch Plan

Today there is a laser focus on product performance out of the gate, so there is a lot of pressure to get it right. This means pharma companies need to make sure that they have the right launch team in place before putting together the structure and tactics in their launch plans. Read to learn more.

Launch Excellence

Navigating a Drug Launch: Part 3 – How to execute

How can reps engage physicians beyond office visits in our digital world? Ultimately, this is what the launch teams need to answer when developing the ‘how to execute’ portion of their strategies.

Launch Excellence

Navigating a Drug Launch: Part 2 – How to Win

Pharma companies that have product launches that repeatedly perform beyond expectations know how to develop vision and positioning, create a brand strategy with notable differentiation, and focus on building superior customer experiences. Learn more.

Launch Excellence

Navigating a Drug Launch: Part 1 – Where to Play?

At Herspiegel, we have partnered with biotech and pharma companies big and small and have successfully brought millions of dollars worth of drugs, devices, and treatments to market. But before we get a product out the door, we help launch teams navigate their go-to-market strategies.

Market Access

Fed-Up Hospitals are Starting Their Own Drug Company to Lower Generic Drug Prices

Read the article about the cost and supply challenges leading to Hospitals needing to start their own drug companies to lower generic drug prices.

Launch Excellence

FDA Continued Rejections of Citizen Petitions Highlights Key Lifecycle Challenges for Biologic Manufacturers

Read about key lifecycle challenges for Biologic Manufacturers in this article.

Launch Excellence

Complete Response Letters are Increasing

Complete Response Letters (CRLs) are increasing. How are pharma companies preparing? Read more.

Market Access

Government Intervention into Drug Pricing: Part Two

In this post, we discuss different approaches that aim to incite competition between branded and generic drug products, as well as an example demonstrating the potential impact of these policies.

Market Access

Government Intervention into Drug Pricing: Part One

This is the first in a four-part series where we will explore the issue of government intervention in drug costs. In this first post, we introduce a few commonly mentioned tactics, two of which we will dig deeper into in subsequent posts.

Medical Affairs

Unveiling Insights: How KOLs Shaped a Groundbreaking Therapy’s Journey

A recent pivotal Phase 3 clinical trial marked a significant milestone for our client, a biopharmaceutical company, in their quest to introduce a novel treatment for major depressive disorder (MDD). Read more.

Roadmap to De-risk Commercialization of a Rare Disease Product

Explore Herspiegel's expert strategies for successful rare disease launches, from tech innovation to market responsiveness. Learn more now.

Market Access

CMS Announces First Drugs for Price Negotiations

The Centers for Medicare & Medicaid Services (CMS) just announced the first set of drugs and biologics for price negotiations to be effective 2026. Read the article to find out more.

Market Access

CMS Price Negotiations – Data Submission Update

Since CMS announced the first ten drugs selected for price negotiation on August 29th, 2023, primary manufacturers had until October 1st, 2023, to sign agreements to participate in the Price Negotiation Program. Read the article to find out more.

Navigating a Drug Launch

Master drug launch success! Herspiegel shares 4-part blog series on de-risking launch plans. Tap into our go-to-market model now.

The Importance of Building a Strong Portfolio of Products with Co-Positioning

Maximize portfolio impact! Learn key co-positioning strategies for products in our latest whitepaper. Boost performance now.

Patient Services

Designing patient support programs that deliver on their promise

Transform patient outcomes with effective support programs. Learn how to create impactful adherence strategies—start now!

Launch Excellence

Oncology Product Launch Toolkit

Master oncology product launches with key strategies for success. Learn vital planning & collaboration tips. Watch our presentation.

Delivering Cell and Gene Therapies at Scale (VIDEO)

Discover cell & gene therapy launch secrets with Beth Schurman & Kate Reedy on Herspiegel Conversations. Watch now.

Inflation Reduction Act Impacts

Uncover how the Inflation Reduction Act revolutionizes Medicare & drug prices. Stay ahead with Herspiegel's insights. Read now.

The Art and Science of Forecasting Drug Launches

Navigate pharma's complex landscape with Herspiegel’s savvy drug launch forecasting. Discover strategies for success. Click to learn more.

Identify Rare Disease Launch Archetypes to Determine Your Optimal Launch Approach

Discover the vast impact of rare diseases affecting 30M Americans & the struggle for diagnosis. Dive deeper into their stories.

Patient Services

Policy Briefing: Executive Order 14091

Uncover how Executive Order 14091 transforms healthcare for underserved communities & what it means for manufacturers. Learn more.

Patient Services

Patient Services Strategy and Design

Discover top strategies for successful patient services in chronic conditions. Watch our presentation for key insights & case study.

Patient Services

Infrastructure to Enable Holistic Patient Support Services

Learn how to build holistic patient support with insights from Herspiegel & Courier Health. Unlock secrets to patient-centric care now.

Patient Services

Evolving Trends in Patient Services

Discover the latest in patient support trends with Brian Torres in this insightful interview. Visit our Hub for more exclusive resources.

Patient Services

Creating Support Programs Where Patients Start, Stay, and Succeed

Gain insights into creating successful patient support programs. Access our exclusive presentations, whitepapers, and case studies. Sign in today.

Market Access

5 Ways the Build Back Better Act Will Reduce Costs

Explore 5 key strategies the Build Back Better Act employs to cut drug costs. Essential insights for pharma strategy. Click to learn more.

267.759.2130